Cargando…
Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel Diseases
Background: Pharmacotherapy with biologics and small molecules, as the more effective therapies for moderate to severe ulcerative colitis (UC) and Crohn’s disease (CD), is complex. Choosing the best methods for their utilization in order to induce and maintain remission are critical for practicing g...
Autores principales: | Khoshnam-Rad, Niloofar, Vahedi, Homayoon, Sadeghi, Anahita, Rastegarpanah, Mansoor, Namazi, Soha, Anushiravani, Amir, Sima, Ali Reza, Shahrokh, Shabnam, Alatab, Sudabeh, Malekzadeh, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404092/ https://www.ncbi.nlm.nih.gov/pubmed/37546508 http://dx.doi.org/10.34172/mejdd.2023.327 |
Ejemplares similares
-
Efficacy of Anti-TNF Therapy for the Treatment of Patients with Moderate-to-Severe Inflammatory Bowel Disease; a First Iranian Report
por: Mohagheghi Darehranj, Samaneh, et al.
Publicado: (2020) -
A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience-Study Protocol
por: Anushiravani, Amir, et al.
Publicado: (2020) -
Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East
por: Malekzadeh, Masoud M, et al.
Publicado: (2019) -
Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households
por: Anushiravani, Amir, et al.
Publicado: (2022) -
Colonoscopy Complications in an Iranian Teaching Hospital
por: Ali Asgari, Ali, et al.
Publicado: (2022)